| Phylogeny and evolution of Newcastle disease virus genotypes isolated in Asia during 2008–2011 MM Ebrahimi, S Shahsavandi, G Moazenijula, M Shamsara Virus genes 45, 63-68, 2012 | 86 | 2012 |
| Application of PCR on detection of aflatoxinogenic fungi AH Shooshtari, S Mohammadi, S Shahsavandi, SA Pourbakhsh, ... Archives of Razi Institute 62 (2), 95-100, 2007 | 49 | 2007 |
| Impact of chicken-origin cells on adaptation of a low pathogenic influenza virus S Shahsavandi, MM Ebrahimi, A Mohammadi, N Zarrin Lebas Cytotechnology 65, 419-424, 2013 | 46 | 2013 |
| Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses S Shahsavandi, MM Ebrahimi, K Sadeghi, H Mahravani Virologica Sinica 30, 200-207, 2015 | 33 | 2015 |
| Evolutionary characterization of hemagglutinin gene of H9N2 influenza viruses isolated from Asia S Shahsavandi, AH Salmanian, SA Ghorashi, S Masoudi, MM Ebrahimi Research in veterinary science 93 (1), 234-239, 2012 | 33 | 2012 |
| Novel applications of immuno-bioinformatics in vaccine and bio-product developments at research institutes MM Ranjbar, MM Ebrahimi, S Shahsavandi, T Farhadi, A Mirjalili, ... Archives of Razi Institute 74 (3), 219-233, 2019 | 26 | 2019 |
| Dose‐and Time‐Dependent Apoptosis Induced by Avian H9N2 Influenza Virus in Human Cells S Shahsavandi, MM Ebrahimi, K Sadeghi, SZ Mosavi, A Mohammadi BioMed research international 2013 (1), 524165, 2013 | 25 | 2013 |
| Development of rHA1-ELISA for specific and sensitive detection of H9 subtype influenza virus S Shahsavandi, AH Salmanian, SA Ghorashi, S Masoudi, F Fotouhi, ... Journal of virological methods 171 (1), 260-263, 2011 | 21 | 2011 |
| In silico design of multimeric HN-F antigen as a highly immunogenic peptide vaccine against Newcastle disease virus MJ Motamedi, J Amani, S Shahsavandi, AH Salmanian International Journal of Peptide Research and Therapeutics 20, 179-194, 2014 | 20 | 2014 |
| Interfering with lipid raft association: A mechanism to control influenza virus infection by Sambucus nigra S Shahsavandi, MM Ebrahimi, AH Farahani Iranian Journal of Pharmaceutical Research: IJPR 16 (3), 1147, 2017 | 17 | 2017 |
| Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus S Shahsavandi, AH Salmanian, SA Ghorashi, S Masoudi, F Fotouhi, ... Molecular biology reports 38, 3293-3298, 2011 | 16 | 2011 |
| Hemokinin-1 molecular adjuvant: an approach to enhance the efficacy of influenza vaccine K Sadeghi, S Shahsavandi, MM Ebrahimi, H Mahravani, H Fazel Arak Med Uni J 17 (11), 62-69, 2014 | 15 | 2014 |
| Replication efficiency of influenza A virus H9N2: a comparative analysis between different origin cell types NZ Lebas, S Shahsavandi, A Mohammadi, MM Ebrahimi, M Bakhshesh Jundishapur journal of microbiology 6 (9), 2013 | 15 | 2013 |
| Improvement efficacy of influenza nanovaccine in combination with hemokinin-1 molecular adjuvant A Dehghan, S Shahsavandi, L Jabalameli Avicenna Journal of Medical Biotechnology 10 (4), 208, 2018 | 14 | 2018 |
| The immunogenicity of a novel chimeric hemagglutinin-neuraminidase-fusion antigen from Newcastle disease virus by oral delivery of transgenic canola seeds to chickens MJ Motamedi, MM Ebrahimi, S Shahsavandi, J Amani, R Kazemi, M Jafari, ... Molecular Biotechnology 62, 344-354, 2020 | 13 | 2020 |
| Improvement influenza HA2 DNA vaccine cellular and humoral immune responses with Mx bio adjuvant S Soleimani, S Shahsavandi, O Maddadgar Biologicals 46, 6-10, 2017 | 13 | 2017 |
| Apoptotic response of chicken embryonic fibroblast cells to infectious bursal disease virus infections reflects viral pathogenicity S Shahsavandi, MM Ebrahimi, K Sadeghi, H Mahravani In Vitro Cellular & Developmental Biology-Animal 50, 858-864, 2014 | 12 | 2014 |
| Necrotic response to low pathogenic H9N2 influenza virus in chicken hepatoma cells SZ Mosavi, S Shahsavandi, MM Ebrahimi, AR Hatami, K Sadeghi, ... Jundishapur journal of microbiology 8 (1), 2015 | 11 | 2015 |
| Immunogenicity of the multi-epitopic recombinant glycoproteins of Newcastle disease virus: implications for the serodiagnosis applications MJ Motamedi, S Shahsavandi, J Amani, R Kazemi, S Takrim, M Jafari, ... Iranian journal of biotechnology 16 (4), 2018 | 10 | 2018 |
| In silico analysis of HA2/Mx chimera peptide for developing an adjuvanted vaccine to induce immune responses against influenza viruses S Soleimani, O Madadgar, S Shahsavandi, H Mahravani, M Lotfi Advanced pharmaceutical bulletin 5 (Suppl 1), 629, 2015 | 9 | 2015 |
